The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Antibiotics produced by Streptomyces
Open accessAbstract
Streptomyces is a genus of Gram-positive bacteria that grows in various environments, and its shape resembles filamentous fungi. The morphological differentiation of Streptomyces involves the formation of a layer of hyphae that can differentiate into a chain of spores. The most interesting property of Streptomyces is the ability to produce bioactive secondary metabolites, such as antifungals, antivirals, antitumorals, anti-hypertensives, immunosuppressants, and especially antibiotics. The production of most antibiotics is species specific, and these secondary metabolites are important for Streptomyces species in order to compete with other microorganisms that come in contact, even within the same genre. Despite the success of the discovery of antibiotics, and advances in the techniques of their production, infectious diseases still remain the second leading cause of death worldwide, and bacterial infections cause approximately 17 million deaths annually, affecting mainly children and the elderly. Self-medication and overuse of antibiotics is another important factor that contributes to resistance, reducing the lifetime of the antibiotic, thus causing the constant need for research and development of new antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
Bentley, S. D., Chater, K. F., Cerdeño-Tárraga, A.-M., Challis, G. L., Thomson, N. R., James, K. D., Harris, D. E., Quail, M. A., Kieser, H., Harper, D., et al. (2002) · Nature · doi:10.1038/417141a · Cited by 3,233
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Call of the wild: antibiotic resistance genes in natural environments
Allen, H. K., Donato, J., Wang, H. H., Cloud-Hansen, K. A., Davies, J., & Handelsman, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2312 · Cited by 2,361
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Costelloe, C., Metcalfe, C., Lovering, A., Mant, D., & Hay, A. D. (2010) · BMJ · doi:10.1136/bmj.c2096 · Cited by 1,981
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
Esfand, R., & Tomalia, D. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01757-3 · Cited by 1,562
How many antibiotics are produced by the genus Streptomyces ?
Watve, M., Tickoo, R., Jog, M., & Bhole, B. (2001) · Archives of Microbiology · doi:10.1007/s002030100345 · Cited by 923
Antibiotic resistance in the environment: a link to the clinic?
Wright, G. D. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.08.005 · Cited by 831
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Ōmura, S., Ikeda, H., Ishikawa, J., Hanamoto, A., Takahashi, C., Shinose, M., Takahashi, Y., Horikawa, H., Nakazawa, H., Osonoe, T., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211433198 · Cited by 801
The role of antibiotics and antibiotic resistance in nature
Aminov, R. I. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01972.x · Cited by 687
Streptomyces morphogenetics: dissecting differentiation in a filamentous bacterium
Flärdh, K., & Buttner, M. J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro1968 · Cited by 667
Evaluation of different detection methods of biofilm formation in the clinical isolates
Hassan, A., Usman, J., Kaleem, F., Omair, M., Khalid, A., & Iqbal, M. (2011) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(11)70197-0 · Cited by 577
Genome Sequence of the Streptomycin-Producing Microorganism Streptomyces griseus IFO 13350
Ohnishi, Y., Ishikawa, J., Hara, H., Suzuki, H., Ikenoya, M., Ikeda, H., Yamashita, A., Hattori, M., & Horinouchi, S. (2008) · Journal of Bacteriology · doi:10.1128/jb.00204-08 · Cited by 563
Why is big Pharma getting out of antibacterial drug discovery?
Projan, S. J. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.003 · Cited by 503
Renaissance in antibacterial discovery from actinomycetes
BALTZ, R. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.04.008 · Cited by 498
The complex extracellular biology of Streptomyces
Chater, K. F., Biró, S., Lee, K. J., Palmer, T., & Schrempf, H. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00206.x · Cited by 495
Qin, S., Li, J., Chen, H.-H., Zhao, G.-Z., Zhu, W.-Y., Jiang, C.-L., Xu, L.-H., & Li, W.-J. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01034-09 · Cited by 445
Antibiotic prescribing in hospitals: a social and behavioural scientific approach
Hulscher, M. E., Grol, R. P., & van der Meer, J. W. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70027-x · Cited by 362
A global view of antibiotic resistance
Martinez, J. L., Fajardo, A., Garmendia, L., Hernandez, A., Linares, J. F., Martínez-Solano, L., & Sánchez, M. B. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00142.x · Cited by 356
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
Natural products — The future scaffolds for novel antibiotics?
Butler, M. S., & Buss, A. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 337
Antibacterial discovery and development—the failure of success?
Fernandes, P. (2006) · Nature Biotechnology · doi:10.1038/nbt1206-1497 · Cited by 246
The evolution of development inStreptomycesanalysed by genome comparisons
Chater, K. F., & Chandra, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2006.00033.x · Cited by 149
Structure-based discovery of antibacterial drugs
Simmons, K. J., Chopra, I., & Fishwick, C. W. G. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2349 · Cited by 145
How many modes of action should an antibiotic have?
Brötz‐Oesterhelt, H., & Brunner, N. A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.008 · Cited by 133
Exploiting current understanding of antibiotic action for discovery of new drugs
Chopra, I., Hesse, L., & O’Neill, A. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.13.x · Cited by 130
Sahoo, K. C., Tamhankar, A. J., Johansson, E., & Lundborg, C. S. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-629 · Cited by 129
Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance
Brazas, M. D., & Hancock, R. E. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03566-x · Cited by 127
Bignell, D. R. D., Seipke, R. F., Huguet‐Tapia, J. C., Chambers, A., Parry, R. J., & Loria, R. (2010) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-23-2-0161 · Cited by 119
Antibacterial drug discovery in the 21st century
Bush, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1465-0691.2004.1005.x · Cited by 106
Postgenomic Strategies in Antibacterial Drug Discovery
Brötz‐Oesterhelt, H., & Saß, P. (2010) · Future Microbiology · doi:10.2217/fmb.10.119 · Cited by 105
Patzer, S. I., & Braun, V. (2009) · Journal of Bacteriology · doi:10.1128/jb.01250-09 · Cited by 94
Khan, S. T., Komaki, H., Motohashi, K., Kozone, I., Mukai, A., Takagi, M., & Shin‐ya, K. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02337.x · Cited by 92
Barbe, V., Bouzon, M., Mangenot, S., Badet, B., Poulain, J., Segurens, B., Vallenet, D., Marlière, P., & Weissenbach, J. (2011) · Journal of Bacteriology · doi:10.1128/jb.05583-11 · Cited by 68
Klebsiella ESBL bacteremia-mortality and risk factors
Tuon, F. F., Kruger, M., Terreri, M., Penteado-Filho, S. R., & Görtz, L. W. (2011) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(11)70257-4 · Cited by 68
Baumgart, A. M. K., Molinari, M. A., & Silveira, A. C. D. O. (2010) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(10)70089-1 · Cited by 55
Functional genomics in antibacterial drug discovery
Freiberg, C., & Brötz‐Oesterhelt, H. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03474-4 · Cited by 47
The antibacterial lead discovery challenge
(2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3289 · Cited by 34
The association between antibiotic use and resistance: the role of secondary antibiotics
Bosso, J. A., Mauldin, P. D., & Salgado, C. D. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0972-5 · Cited by 24
Dienstmann, R., Picoli, S. U., Meyer, G., Schenkel, T., & Steyer, J. R. (2010) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442010000100005 · Cited by 19
Política de antibióticos en pacientes críticos
Lerma, F. Á., Camerino, R. S., Rocha, L. Á., & Colomo, Ó. R. (2010) · Medicina Intensiva · doi:10.1016/j.medin.2010.03.001 · Cited by 19
Genética y genómica enfocadas en el estudio de la resistencia bacteriana
Garza–Ramos, U., Silva-Sánchez, J., & Martínez‐Romero, E. (2009) · Salud Pública de México · doi:10.1590/s0036-36342009000900009 · Cited by 14
Cited by
Plant Growth Promoting and Biocontrol Activity of Streptomyces spp. as Endophytes
Vurukonda, S. S. K. P., Giovanardi, D., & Stefani, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040952 · Cited by 652
A Review of the Microbial Production of Bioactive Natural Products and Biologics
Pham, J. V., Yilma, M. A., Feliz, A., Majid, M. T., Maffetone, N., Walker, J. R., Kim, E., Cho, H. J., Reynolds, J. M., Song, M. C., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01404 · Cited by 565
Streptomyces: The biofactory of secondary metabolites
Alam, K., Mazumder, A., Sikdar, S., Zhao, Y.-M., Hao, J., Song, C., Wang, Y., Sarkar, R., Islam, S., Zhang, Y., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.968053 · Cited by 456
The chicken gut metagenome and the modulatory effects of plant-derived benzylisoquinoline alkaloids
Huang, P., Zhang, Y., Xiao, K., Jiang, F., Wang, H., Tang, D., Liu, D., Liu, B., Liu, Y., He, X., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0590-5 · Cited by 340
Law, J. W.-F., Ser, H.-L., Khan, T. M., Chuah, L.-H., Pusparajah, P., Chan, K.-G., Goh, B.-H., & Lee, L.-H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00003 · Cited by 331
Metadata
- Authors
- de Lima Procópio, R. E., da Silva, I. R., Martins, M. K., de Azevedo, J. L., & de Araújo, J. M.
- Venue
- The Brazilian Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 16
- Issue
- 5
- Pages
- 466-471
- ISSN
- 1413-8670 (ISSN-L)
- OpenAlex
- W2025155908
- Cited by
- 735
- References
- 46
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.